论文部分内容阅读
中国企业海外并购,正在成为一个新的风向标。近日,中国化工成功收购瑞士农药巨头先正达,引人瞩目。中国化工在买到有形资产的同时,也获得了先正达大量专利、商标等知识产权,可谓是买到赚到。但是,在近年来的海外并购中,一些案例的知识产权情况并不尽如人意,同样应该引起高度重视,趋利避害是应有之义。回首近年来中国企业的海外并购,成功者有之,失利者有之,可谓是
Chinese companies overseas acquisitions, is becoming a new benchmark. Recently, China Chemical successfully acquired syndicate giant Swiss pesticide, attracting attention. At the same time that China National Chemical bought tangible assets, it also acquired a large number of Syngenta patents, trademarks and other intellectual property rights, which can be described as buying and earning. However, in recent years, overseas IPOs have not been satisfactory in some cases. It should also be given the same priority. Looking back on the overseas mergers and acquisitions of Chinese enterprises in recent years, there are successful people, losers have it, can be described as